Literature DB >> 10631960

A therapeutic use of the methadone fluvoxamine drug interaction.

P A DeMaria1, R D Serota.   

Abstract

BACKGROUND: Methadone has been effectively used in the treatment of opiate dependence. Adequate dose and blood level have correlated with success in treatment. A number of factors including the regular use of alcohol, medications, and urinary pH can influence blood level and thereby effectiveness. Fluvoxamine has been shown to increase methadone blood levels.
METHODS: Single case report.
RESULTS: A patient unable to maintain an effective methadone blood level despite a dose of 200 mg per day was administered fluvoxamine with subsequent increase in her methadone blood level and reduction of opiate withdrawal symptoms.
CONCLUSIONS: In patients unable to maintain an effective methadone blood level throughout the dosing interval, fluvoxamine can help increase the methadone blood level and alleviate opiate withdrawal symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631960     DOI: 10.1300/J069v18n04_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  5 in total

Review 1.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.

Authors:  R Brown; C Kraus; M Fleming; S Reddy
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

Review 3.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

Review 4.  What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.

Authors:  Angelo G I Maremmani; Matteo Pacini; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-02-03       Impact factor: 3.390

Review 5.  Practical considerations for the clinical use of buprenorphine.

Authors:  Hendree E Jones
Journal:  Sci Pract Perspect       Date:  2004-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.